Experic, a contract development and manufacturing organization (CDMO) and pharmaceutical supply services company, supports every phase of a product’s life cycle from clinical to commercial scale, across a range of dosing and packaging formats.
Experic provides customized services for dry powder inhalation products. With more than 15 years of experience dedicated to the formulation and development of inhaled products, the Experic team of leading scientific and engineering experts will support your project at every stage of development.
Experic’s quality-by-design approach and scalable capabilities for precision filling, assembly, packaging, and logistics of reservoir-based and single-dose dry powder inhalation products ensure efficient delivery of the right solution for every DPI project. For more information, visit www.expericservices.com
Experic
2 Clarke Drive
Cranbury, NJ 08512
USA
+1 609 537 4040
expericservices.com
info@expericservices.com
Customized and Scalable Dry Powder Inhalation (DPI) Product Development Services
With an experienced team, Experic offers state-of-the-art dry powder inhalation (DPI) capabilities and comprehensive services from DPI development and GMP manufacturing to packaging and distribution. More Info
Solve Development Scale Powder Challenges with Spray Drying Technology
In DPI formulations, particle engineering is a necessity for achieving both the product TPP and delivery to the lungs. Experic spray drying can help control particle size and morphology and enhance bioavailability. More Info
Analytical Services that Provide Powerful Support at Every Phase
Experic’s analytical services support formulation and process development, release testing of raw materials, API, and finished products, method development & validation, analysis of in-process samples, stability studies, and more. More Info
Inhaled Biologics: Formulation, Analysis and Regulation
As inhalation developers and manufacturers, how do we support the complexities of new biologics products? In this white paper, Justin Lacombe, Ph.D., Chief Scientific Officer, Experic, explores how we need to change our approach for biologics. More Info
